Besides, BSN-AS2 differentially expressed in pheochromocytoma (PCC) samples and was recognized as an independent prognostic biomarker and potential therapeutic target for PCC [19]. The gene discussed is BSN-DT; the disease is adrenal gland pheochromocytoma.